RONALD R. BLANCK, DO - Corporate Board Profile

TENAX THERAPEUTICS, INC.

Filing Date	Source Excerpt
2010-08-27	Ronald R. Blanck, DO has served as a director since December 2009. He serves on the Audit and Compliance Committee, Corporate Governance and Nominating Committee, and Development Committee (Chair). 2010 Director Compensation table shows total compensation of $151,153.
2011-09-06	Ronald R. Blanck, DO has served as a director since December 2009. Dr. Blanck has served as chairman of Martin, Blanck & Associates, a federal health services consulting firm based in Falls Church, VA since January 2010. He began his military career in 1968 as a medical officer and battalion surgeon in Vietnam, retiring 32 years later as a Lieutenant General and Surgeon General of the U.S. Army and commander of the U.S. Army Medical Command. He also served as commander of Walter Reed Medical Center and the North Atlantic Region Medical Command. His background also includes serving as president of the University of North Texas Health Science Center at Fort Worth. Dr. Blanck brings to the Board an intimate knowledge of our military system and the unique health care challenges they face. As a director, Dr. Blanck has provided invaluable assistance to the Board as our company strives to bring innovative medical products to our wounded military men and women. The members of the Audit and Compliance Committee are Messrs. Engle and Eckert and Dr. Blanck. Mr. Engle serves as chair of the Audit Committee. The Board of Directors has determined that Mr. Engle is an “audit committee financial expert” as defined by applicable SEC rules. The Audit Committee met six times in fiscal 2011. The members of the Development Committee currently are Drs. Blanck, Klein and Kiral, and Mr. Pepin. Dr. Blanck serves as chair of the Development Committee. The Development Committee met one time in fiscal 2011. The members of the Corporate Governance and Nominating Committee are Messrs. Chatfield and Eckert, Engle and Dr. Blanck. Mr. Chatfield serves as chair of the Corporate Governance and Nominating Committee. The Corporate Governance and Nominating Committee met one time in fiscal 2011.
2012-08-01	Ronald R. Blanck, DO has served as a director since December 2009 and as Chairman since September 2011. Dr. Blanck serves on the Corporate Governance and Nominating Committee, the Compensation Committee, and as chair of the Audit Committee. 2012 Director Compensation: Ronald R. Blanck, DO - Total: $80,500.
2013-03-28	Ronald R. Blanck, DO Amount and Nature of Beneficial Ownership 35,989 Percent *
2013-11-04	Ronald R. Blanck, DO has served as a director since December 2009 and as Chairman since September 2011. Dr. Blanck serves on the Corporate Governance and Nominating Committee, the Compensation Committee, and as chair of the Audit Committee. 2013 Director Compensation table shows total compensation of $74,000.
2014-02-04	2013 Director Compensation Director Fees Earned or Paid in Cash ($) Option Awards ($) Stock Awards ($) All Other Compensation ($) Total ($) Ronald R. Blanck, DO(1) 40,249 — 33,751 — 74,000
2014-08-12	Ronald R. Blanck, DO has served as a director since December 2009 and as Chairman since September 2011. Dr. Blanck serves as a member of the Corporate Governance and Nominating Committee, and as chair of the Audit Committee. 2014 Director Compensation: Ronald R. Blanck, DO Fees Earned or Paid in Cash $34,750, Option Awards $37,000, Total $71,750.
2015-08-17	Ronald R. Blanck, DO has served as a director since December 2009 and as Chairman since September 2011. Dr. Blanck serves as a member of the Corporate Governance and Nominating Committee and as chair of the Audit Committee. 2015 Director Compensation table shows total compensation of $109,607.
2016-04-26	Ronald R. Blanck, DO has served as a director since December 2009 and as Chairman since September 2011. Dr. Blanck serves as a member of the Corporate Governance and Nominating Committee and as chair of the Audit and Compliance Committee. Transition Period 2015 Director Compensation: $72,221 total.
2017-04-28	Ronald R. Blanck, DO has served as a director since December 2009 and as Chairman since September 2011. Dr. Blanck serves as a member of the Corporate Governance and Nominating Committee and the Audit and Compliance Committee.
2018-01-16	With respect to Dr. Blanck, includes 5,129 shares of common stock subject to warrants and 40,507 shares of common stock subject to options that are vested, vesting, exercisable or convertible, as applicable, within 60 days of December 28, 2017;
2018-04-20	Ronald R. Blanck, DO has served as a director since December 2009 and as Chairman since September 2011. Dr. Blanck serves as a member of the Corporate Governance and Nominating Committee and the Audit and Compliance Committee.
2019-04-19	Ronald R. Blanck, DO has served as a director since December 2009 and as Chairman since September 2011. Dr. Blanck has served as chairman and partner of Martin, Blanck & Associates, a federal health services consulting firm based in Falls Church, VA since August 2006. Dr. Blanck has also served as director and chairman of Pyng Medical Corp, a medical device company since July 2012 and as chairman of VetFed Resources, Inc., a health solutions provider, since July 2015. He began his military career in 1968 as a medical officer and battalion surgeon in Vietnam, retiring 32 years later as a Lieutenant General and Surgeon General of the U.S. Army and commander of the U.S. Army Medical Command. He also served as commander of Walter Reed Medical Center and the North Atlantic Region Medical Command. His background also includes serving as president of the University of North Texas Health Science Center at Fort Worth, chair of the Board of Regents of Uniformed Services University of the Health Sciences and chair of the Education Commission on Foreign Medical Graduates. Dr. Blanck has also been recognized as a Master of the American College of Physicians. We believe Dr. Blanck’s extensive medical background and treatment of critical care patients qualify him to serve on our Board and his many leadership positions throughout his military career qualify him to serve as our Chairman of the Board. Dr. Blanck serves as a member of the Corporate Governance and Nominating Committee and the Audit and Compliance Committee. Fiscal 2018 Director Compensation: Fees Earned or Paid in Cash $66,000, Option Awards $2,624, Total $68,624.
2020-04-29	Ronald R. Blanck, DO has served as a director since December 2009 and as Chairman since September 2011. Dr. Blanck serves as a member of the Corporate Governance and Nominating Committee and the Audit and Compliance Committee. Fiscal 2019 Director Compensation: Ronald R. Blanck, DO - Fees Earned or Paid in Cash: $66,000, Option Awards: $735, Total: $66,735.